» Articles » PMID: 7397054

Studies on the Clinical Pharmacology of Prazosin. II: The Influence of Indomethacin and of Propranolol on the Action and Disposition of Prazosin

Overview
Specialty Pharmacology
Date 1980 Jul 1
PMID 7397054
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

1 The possibility of pharmacodynamic and pharmacokinetic interactions of prazosin with indomethacin and with propranolol have been studied in healthy subjects. 2 In four out of nine individuals indomethacin considerably attenuated prazosin-induced hypotension, but noradrenaline concentrations were unchanged from the day when blood pressure fell greatly. The effect of prazosin in the other five subjects was not influenced by indomethacin. 3 Indomethacin prevented the rise in plasma renin activity seen following administration of prazosin alone. 4 Propranolol did not prevent the syncope associated with the first dose of prazosin. 5 Propranolol affected neither the absorption nor elimination of prazosin. 6 It is concluded that in certain subjects indomethacin can largely prevent the hypotensive effect of parazosin, possible by increasing adrenergic receptor sensitivity. The theoretical possibility that propranolol could influence prazosin disposition or syncope was not substantiated.

Citing Articles

The effect of nonsteroidal anti-inflammatory drugs on blood pressure in patients treated with different antihypertensive drugs.

Morgan T, Anderson A J Clin Hypertens (Greenwich). 2003; 5(1):53-7.

PMID: 12556654 PMC: 8101828. DOI: 10.1111/j.1524-6175.2003.00514.x.


Nonsteroidal anti-inflammatory drugs and hypertension. The risks in perspective.

de Leeuw P Drugs. 1996; 51(2):179-87.

PMID: 8808162 DOI: 10.2165/00003495-199651020-00001.


Bunazosin in patients with impaired hepatic or renal function.

Halabi A, Nokhodian A, Kirch W Eur J Drug Metab Pharmacokinet. 1993; 18(3):309-13.

PMID: 7908631 DOI: 10.1007/BF03188813.


Prazosin first dose phenomenon during combined treatment with a beta-adrenoceptor blocker in hypertensive patients.

Seideman P, Grahnen A, Haglund K, Lindstrom B, von Bahr C Br J Clin Pharmacol. 1982; 13(6):865-70.

PMID: 7093116 PMC: 1402032. DOI: 10.1111/j.1365-2125.1982.tb01880.x.


Interaction between oxprenolol and indomethacin on blood pressure in essential hypertensive patients.

Salvetti A, Arzilli F, Pedrinelli R, Beggi P, Motolese M Eur J Clin Pharmacol. 1982; 22(3):197-201.

PMID: 7049707 DOI: 10.1007/BF00545214.


References
1.
Branch R, SHAND D, Wilkinson G, Nies A . The reduction of lidocaine clearance by dl-propranolol: an example of hemodynamic drug interaction. J Pharmacol Exp Ther. 1973; 184(2):515-9. View

2.
Branch R, SHAND D, Nies A . Hemodynamic drug interactions: the reduction of oxyphenbutazone clearance by dl-propranol in the dog. J Pharmacol Exp Ther. 1973; 187(1):133-7. View

3.
Harrison D, Fitzgerald J, Winkle R . Ambulatory electrocardiography for diagnosis and treatment of cardiac arrhythmias. N Engl J Med. 1976; 294(7):373-80. DOI: 10.1056/NEJM197602122940706. View

4.
Frolich J, Hollifield J, Dormois J, Frolich B, Seyberth H, MICHELAKIS A . Suppression of plasma renin activity by indomethacin in man. Circ Res. 1976; 39(3):447-52. DOI: 10.1161/01.res.39.3.447. View

5.
Bartter F, GILL Jr J, Frolich J, Bowden R, Hollifield J, Radfar N . Prostaglandins are overproduced by the kidneys and mediate hyperreninemia in Bartter's syndrome. Trans Assoc Am Physicians. 1976; 89:77-91. View